Similar articles

• Randomized phase III trial comparing induction chemotherapy followed by radiotherapy to concomitant chemoradiotherapy for laryngeal preservation in T3M0 pyriform sinus carcinoma.

  Prades JM, Lallemant B, Garrel R, Reyt E, Righini C, Schmitt T, Remini N, Saban-Roche L, Timoshenko AP, Trombert B, Guerrier B. Prades JM, et al. Acta Otolaryngol. 2010;130(1):150-5. doi: 10.3109/00016480902914080. Acta Otolaryngol. 2010. PMID: 19449227 Clinical Trial.
• Larynx preservation: what is the best non-surgical strategy?

  Lagha A, Chraiet N, Labidi S, Rifi H, Ayadi M, Krimi S, Allani B, Raies H, Touati S, Boussen H, Kochbati L, Mezlini A. Lagha A, et al. Crit Rev Oncol Hematol. 2013 Nov;88(2):447-58. doi: 10.1016/j.critrevonc.2013.05.005. Epub 2013 Jun 5. Crit Rev Oncol Hematol. 2013. PMID: 23755889 Review.
• Larynx preservation protocols: long-term functional outcomes in good responders to induction chemotherapy for pyriform sinus carcinoma.

  Vourexakis Z, Janot F, Dulguerov P, Le Ridant AM. Vourexakis Z, et al. ORL J Otorhinolaryngol Relat Spec. 2014;76(3):165-70. doi: 10.1159/000365394. Epub 2014 Jul 29. ORL J Otorhinolaryngol Relat Spec. 2014. PMID: 25074814
• Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.

  Sakashita T, Homma A, Hatakeyama H, Furusawa J, Kano S, Mizumachi T, Iizuka S, Onimaru R, Tsuchiya K, Yasuda K, Shirato H, Fukuda S. Sakashita T, et al. Int J Clin Oncol. 2015 Dec;20(6):1081-5. doi: 10.1007/s10147-015-0821-8. Epub 2015 Mar 25. Int J Clin Oncol. 2015. PMID: 25804347
• Early stage squamous cell carcinoma of the pyriform sinus: a review of treatment options.

  Krstevska V. Krstevska V. Indian J Cancer. 2012 Apr-Jun;49(2):236-44. doi: 10.4103/0019-509X.102920. Indian J Cancer. 2012. PMID: 23107977 Review.